Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia

Clinical Microbiology and Infection, 04/17/2012

Authors assessed the comparative efficacy of empirical therapy with beta–lactam plus macrolide vs. beta–lactam plus doxycycline for the treatment of community–acquired pneumonia (CAP) among patients in the Australian Community–Acquired Pneumonia Study. Both regimens demonstrated similar outcomes against CAP due to either ‘atypical’ or typical bacterial pathogens.

Print Article Summary Cat 2 CME Report